Saxenda weight loss

Saxenda is the brand name for liraglutide, a glucagon‑like peptide‑1 (GLP‑1) receptor agonist approved for chronic weight management. It is administered as a once‑daily subcutaneous injection and carries a boxed warning about potential thyroid C‑cell tumors; it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Saxenda has been approved for adult obesity treatment and for certain adolescent patients, and the official prescribing information provides detailed dosing and safety guidance.